3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Breast Neoplasms
14
Polycystic Ovary Syndrome
9
Neoplasms
5
Endometrial Neoplasms
3
Prostatic Neoplasms
2
Peripheral Nervous System Diseases
2
Obesity
2
Neoplasm Metastasis
2
Multiple Myeloma
2
Melanoma
2
Leukemia, Myeloid, Acute
2
Leiomyoma
2
Insulin Resistance
2
Inflammation
2
Infertility, Female
2
Glioblastoma
2
Diabetes Mellitus
2
Colorectal Neoplasms
2
Cognitive Dysfunction
2
Cardiotoxicity
2
Weight Gain
1
Vomiting
1
Venous Thromboembolism
1
Vascular Malformations
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Triple Negative Breast Neoplasms
1
Thrombocythemia, Essential
1
Stem Cell Transplant Complications
1
Interventions
Cisplatin
3
Radiotherapy
2
Deglutition
2
Cryotherapy
2
Brachytherapy
2
Acupuncture Therapy
2
tislelizumab
1
pembrolizumab
1
epigallocatechin gallate
1
durvalumab
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
auricularum
1
Tablets
1
Standard of Care
1
Respiratory Function Tests
1
Resistance Training
1
Range of Motion, Articular
1
Radiotherapy, Intensity-Modulated
1
Radiation
1
Pravastatin
1
Parenteral Nutrition
1
Nivolumab
1
Musculoskeletal Manipulations
1
Lead
1
Immunotherapy
1
Gastropexy
1
Fundoplication
1
Fluorouracil
1
Exercise
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Deglutition Disorders
×
Tablets
×
Clear all
NCT07217938
2026-03-03
TRADstat
Peter MacCallum Cancer Centre, Australia
Phase 2
Recruiting
48 enrolled